JS Global Lifestyle (1691) heads into its August 28 interim results with the most hostile borrow market in its recent history — and the stock has just staged a sharp rally that is making that borrow even more expensive to maintain.
The dominant story this week is cost to borrow. Borrow costs have exploded from a negligible 2–5% range through most of July to 43% by August 21 — a move of roughly 2,600% over the past month. The spike has been violent and choppy: costs hit nearly 70% intraday on August 17 before settling back, and have since oscillated between 27% and 53% through the final week. That kind of volatility in the lending market typically signals a scramble for borrows — shorts under pressure trying to roll or exit positions while new borrowers compete for diminishing supply.
Availability tells the same story. The share lending pool has tightened sharply, with availability dropping to 38.5% — meaning roughly one share is available for every 2.6 already borrowed. A week ago, availability was closer to 50%. The 52-week tightest reading was 35.6%, hit on August 19, suggesting the pool came close to its floor at the peak of the squeeze before stabilising marginally. At these levels, new short positions are not cheap to establish. Short interest itself has been retreating — down 8.4% on the week and 13% over the past month to 4.6% of the free float — a clear sign that some bears have been closing out rather than fighting a rising stock into an earnings print.
The price move explains part of the pressure. 1691 jumped 7.5% on August 21 alone and is up 12% on the week, bringing the one-month gain to 9.4%. The last comparable result was the August 14 interim print, where the stock gained 10% on the day and 16.7% over the following five days — a strong historical reaction that the current positioning is almost certainly referencing. Bears who held through that event learned a costly lesson; the borrow-cost spike and short interest decline this week suggest many are not willing to repeat it. The ORTEX short score has surged to 96.4 — a near-extreme reading that has been climbing almost every session since August 10, when it was 85.1. That level reflects not just the high short interest percentage but the deteriorating borrow conditions and the price momentum running against the shorts.
The fundamental picture offers some support for the bulls, though analyst data is thin. Three buy ratings are on record, but the mean price target of HK$0.25 looks irreconcilable with the current HK$1.575 share price and should be disregarded as stale. Valuation multiples are undemanding — the stock trades at 6.2x trailing earnings and less than book value at 0.87x price-to-book, with EV/EBITDA below 1.8x. EPS momentum scores rank in the 73rd and 80th percentiles on 30- and 90-day horizons respectively, and the analyst recommendation differential factor ranks in the 96th percentile. The dividend score is elevated at 80, though the most recent dividend on record dates to 2022, making any yield calculation unreliable. Founding Chairman and CEO Xuning Wang, who controls around 55% of shares, made substantial open-market purchases in January 2025 — over 400 million shares across multiple tranches at prices between HK$1.49 and HK$1.59 — providing a long-term cost basis close to the current level. That data is now stale, but the ownership structure leaves little ambiguity about whose conviction anchors the register.
The next event to watch is the August 28 interim results. With borrow costs still running above 40%, short interest in active retreat, availability near its tightest levels of the year, and the short score at a near-record 96.4, the setup into that print is the sharpest tension the stock has seen in months — whether the borrow market stabilises or tightens further into Thursday will be the clearest signal of how nervous remaining short-sellers are.
See the live data behind this article on ORTEX.
Open 1691 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
